Does TACROLIMUS Cause Secondary immunodeficiency? 161 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Secondary immunodeficiency have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
161
Reports of Secondary immunodeficiency with TACROLIMUS
0.2%
of all TACROLIMUS reports
15
Deaths
106
Hospitalizations
How Dangerous Is Secondary immunodeficiency From TACROLIMUS?
Of the 161 reports, 15 (9.3%) resulted in death, 106 (65.8%) required hospitalization, and 4 (2.5%) were considered life-threatening.
Is Secondary immunodeficiency Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 161 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Secondary immunodeficiency?
PREDNISONE (402)
CYCLOPHOSPHAMIDE (362)
VINCRISTINE (331)
DEXAMETHASONE (282)
METHOTREXATE (280)
METHYLPREDNISOLONE (255)
CYTARABINE (250)
MERCAPTOPURINE (241)
DAUNORUBICIN (240)
ETOPOSIDE (240)
Which TACROLIMUS Alternatives Have Lower Secondary immunodeficiency Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB